Iovance TIL Appeal Seen Luring Potential Buyers

Media Reports Say US Biotech Is In Active M&A Talks

Shares in Iovance Biotherapeutics have soared this week amid reports the US clinical-stage biotechnology company is in active M&A talks.

US_Dollars_MandA
Iovance specializes in cell therapy focused on treating solid tumors • Source: Shutterstock

More from Business

More from Scrip